Literature DB >> 27160301

Laparoscopic Nephron Sparing Surgery Assisted with Laparoscopic Ultrasonography on Centrally Located Renal Tumor - Single Center Experience.

Dexin Dong1, Zhigang Ji, Hanzhong Li, Weigang Yan, Yushi Zhang.   

Abstract

OBJECTIVE: To investigate the clinical value of laparoscopic nephron sparing surgery (LNSS) assisted with laparoscopic ultrasonography (LUS) on centrally located renal tumors.
MATERIALS AND METHODS: Clinical data of 19 patients who underwent LNSS on centrally located renal tumors assisted with LUS were retrospectively analyzed. LUS was used to confirm the location, size, blood supply, and boundary of renal tumors, and to confirm that the tumor was removed completely with negative margin.
RESULTS: The 19 centrally located renal tumors were deep in renal parenchyma without obvious convex. Eleven cases were in the middle of the kidney, 3 cases were in the upper pole, and 5 cases were in the inferior pole. The tumor size was in the range 1.0-3.9 cm, with an average of 2.46 cm. The pathological results were 13 cases of renal clear cell carcinoma, 1 case of reninoma, 1 case of renal cyst, and 3 cases of angioleiomyolipoma. The surgical margins were negative in all 19 cases.
CONCLUSIONS: LUS has a high clinical value in LNNS on centrally located renal tumors and it helps to determine the location of centrally located tumors and guarantee negative margins.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27160301     DOI: 10.1159/000446026

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

Review 1.  Juxtaglomerular Cell Tumor: Reviewing a Cryptic Cause of Surgically Correctable Hypertension.

Authors:  Rafid Inam; Jason Gandhi; Gunjan Joshi; Noel L Smith; Sardar Ali Khan
Journal:  Curr Urol       Date:  2019-09-10

Review 2.  Laparoscopic ultrasonography: The wave of the future in renal cell carcinoma?

Authors:  Bitian Liu; Yunhong Zhan; Xiaonan Chen; Qingpeng Xie; Bin Wu
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.